|
Name |
Decahydro-4,8,8-trimethyl-1,4-methanoazulene-9-carbaldehyde
|
Molecular Formula | C15H24O | |
IUPAC Name* |
3,3,7-trimethyltricyclo[5.4.0.02,9]undecane-8-carbaldehyde
|
|
SMILES |
CC1(CCCC2(C3C1C(C2C=O)CC3)C)C
|
|
InChI |
InChI=1S/C15H24O/c1-14(2)7-4-8-15(3)11-6-5-10(13(11)14)12(15)9-16/h9-13H,4-8H2,1-3H3
|
|
InChIKey |
PBMHTGOFWRRJFS-UHFFFAOYSA-N
|
|
Synonyms |
Longifolenaldehyde; Decahydro-4,8,8-trimethyl-1,4-methanoazulene-9-carbaldehyde; 79645-28-6; Longifolenealdehyde; EINECS 279-209-6; SCHEMBL3001348; DTXSID801182423; Q67880180; Decahydro-4,8,8-trimethyl-1,4-methanoazulene-9-carboxaldehyde
|
|
CAS | 79645-28-6 | |
PubChem CID | 565584 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 220.35 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 16 | QED Weighted: | 0.599 |
Caco-2 Permeability: | -4.716 | MDCK Permeability: | 0.00001510 |
Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.019 |
30% Bioavailability (F30%): | 0.808 |
Blood-Brain-Barrier Penetration (BBB): | 0.916 | Plasma Protein Binding (PPB): | 53.39% |
Volume Distribution (VD): | 3.536 | Fu: | 20.25% |
CYP1A2-inhibitor: | 0.184 | CYP1A2-substrate: | 0.644 |
CYP2C19-inhibitor: | 0.15 | CYP2C19-substrate: | 0.873 |
CYP2C9-inhibitor: | 0.281 | CYP2C9-substrate: | 0.484 |
CYP2D6-inhibitor: | 0.054 | CYP2D6-substrate: | 0.734 |
CYP3A4-inhibitor: | 0.242 | CYP3A4-substrate: | 0.312 |
Clearance (CL): | 14.985 | Half-life (T1/2): | 0.107 |
hERG Blockers: | 0.027 | Human Hepatotoxicity (H-HT): | 0.126 |
Drug-inuced Liver Injury (DILI): | 0.05 | AMES Toxicity: | 0.026 |
Rat Oral Acute Toxicity: | 0.177 | Maximum Recommended Daily Dose: | 0.614 |
Skin Sensitization: | 0.818 | Carcinogencity: | 0.059 |
Eye Corrosion: | 0.023 | Eye Irritation: | 0.071 |
Respiratory Toxicity: | 0.687 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002543 | 0.518 | D0U3GL | 0.329 | ||||
ENC002221 | 0.426 | D0Q6NZ | 0.325 | ||||
ENC003118 | 0.417 | D04DJN | 0.321 | ||||
ENC000704 | 0.406 | D00VZZ | 0.317 | ||||
ENC001350 | 0.391 | D06XMU | 0.304 | ||||
ENC003088 | 0.381 | D0B4RU | 0.301 | ||||
ENC000956 | 0.381 | D07BSQ | 0.301 | ||||
ENC002923 | 0.379 | D08QKJ | 0.287 | ||||
ENC001452 | 0.368 | D04SFH | 0.287 | ||||
ENC001075 | 0.358 | D0F1UL | 0.286 |